Shilpa Medicare Limited Revenue Breakdown – NSE:SHILPAMED
NiveshIQ
NSE: SHILPAMED · Healthcare
Shilpa Medicare Ltd.
₹604.60▼ ₹0.60 (-0.10%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on SHILPAMED. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Shilpa Medicare Ltd.
Shilpa Medicare Limited is a leading Indian pharmaceutical company that manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, and contract development and manufacturing organisation in key international markets. The company offers a diverse portfolio of oncology and non-oncology APIs, with a strong presence in the US, Europe, and India. Recent appointments of Dr. Vellaian Karuppiah as Chief Operating Officer - Formulations, following the retirement of Dr. Jayant Karajgi, are expected to drive business growth and efficiency. Shilpa Medicare Limited has reported a revenue of ₹1433 Cr and a net income of ₹150 Cr, with an analyst target price of ₹517. The company's strong product offerings, expanding global presence, and strategic leadershi
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹1,152 Cr +10.10% | ₹1,287 Cr +11.70% | ₹1,539 Cr +19.60% |
| EBITDA Margin | 20.75% | 24.40% | 28.89% |
| Net Profit | ₹32.00 Cr -203.20% | ₹79.00 Cr +146.90% | ₹214.05 Cr +170.90% |
| EPS | ₹1.83 | ₹4.00 | ₹12.44 |
Annual figures in Indian Rupees (Crores). Source: BSE filings.
Recent News
Shilpa Medicare announces resignation of CEO Dr. Sridevi Khambhampaty from Shilpa Biologicals
Shilpa Medicare announces resignation of CEO Dr. Sridevi Khambhampaty from Shilpa Biologicals
🔒
+ 3 more stories about Shilpa Medicare Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q3FY26 results: revenue ₹410 Cr, PAT ₹45 Cr, EPS ₹2.28, EBITDA margin 27.8%. Growth context: revenue YoY +28.5%, PAT YoY +40.6%, revenue QoQ +10.8%, PAT QoQ +2.3%.
No specific capex or expansion announcements have been filed recently; demand conversion and margin discipline on the co...
Forward consensus estimates for the next FY will be the key financial watchpoint as the current year plays out....
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantEverything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for SHILPAMED
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track SHILPAMED alongside your other holdings
Unlock full SHILPAMED research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Shilpa Medicare Ltd.?
NiveshIQ detects active intelligence signals for Shilpa Medicare Ltd. (SHILPAMED) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Shilpa Medicare Ltd.?
Shilpa Medicare Ltd. operates in the Healthcare sector with a market capitalisation of ₹848,825.1L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.